BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Naqvi SAR. 99m Tc-labeled antibiotics for infection diagnosis: Mechanism, action, and progress. Chem Biol Drug Des 2022;99:56-74. [PMID: 34265177 DOI: 10.1111/cbdd.13923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Jiang Y, Fang S, Feng J, Ruan Q, Zhang J. Synthesis and Bioevaluation of Novel Technetium-99m-Labeled Complexes with Norfloxacin HYNIC Derivatives for Bacterial Infection Imaging. Mol Pharm 2023;20:630-40. [PMID: 36398935 DOI: 10.1021/acs.molpharmaceut.2c00830] [Reference Citation Analysis]
2 Welling MM, Warbroek K, Khurshid C, van Oosterom MN, Rietbergen DDD, de Boer MGJ, Nelissen RGHH, van Leeuwen FWB, Pijls BG, Buckle T. A radio- and fluorescently labelled tracer for imaging and quantification of bacterial infection on orthopaedic prostheses : a proof of principle study. Bone Joint Res 2023;12:72-9. [PMID: 36649933 DOI: 10.1302/2046-3758.121.BJR-2022-0216.R1] [Reference Citation Analysis]
3 Naqvi SAR, Jabbar T, Alharbi MA, Noureen A, Alharbi NK, Sherazi TA, Shahzadi A, Ahmed AE, Afzal MS, Imran MB. Radiosynthesis, quality control, biodistribution, and infection-imaging study of a new 99mTc-labeled ertapenem radiopharmaceutical. Front Chem 2022;10. [DOI: 10.3389/fchem.2022.1020387] [Reference Citation Analysis]
4 Dadachova E, Rangel DEN. Highlights of the Latest Developments in Radiopharmaceuticals for Infection Imaging and Future Perspectives. Front Med 2022;9:819702. [DOI: 10.3389/fmed.2022.819702] [Reference Citation Analysis]